Target intelligence / Profile preview

DNA metabolism

Molecular classification
Biological process, Metabolic pathway
01

Overview

DNA metabolism is a broad biological category encompassing the integrated network of biochemical pathways responsible for the synthesis, replication, repair, and modification of DNA (Nature Education, 2014). It is essential for maintaining genomic integrity, ensuring the accurate transmission of genetic information during cell division, and responding to DNA damage caused by endogenous or environmental factors (NIH/NCBI, 2023). While not a single therapeutic target itself, DNA metabolism contains numerous specific enzymes and receptors—such as DNA polymerases, topoisomerases, and PARP proteins—that serve as critical targets in oncology and infectious disease (StatPearls, 2023). Dysregulation of DNA metabolism is a hallmark of cancer, where increased replication stress or defective repair pathways are exploited by chemotherapeutic agents to induce selective cytotoxicity (Cell, 2015). Drugs targeting these processes often work by inhibiting nucleotide synthesis, creating physical barriers to replication through cross-linking, or trapping repair enzymes on the DNA strand. However, because these processes are also vital for normal cell function, therapeutic intervention often carries significant safety concerns, including myelosuppression and the potential for secondary cancers.

Other names
Genome maintenanceDNA processingDNA synthesis and repairDNA metabolic process
02

Mechanism of action

Inhibition of DNA synthesis, induction of DNA cross-links, inhibition of DNA repair enzymes (e.g., PARP), and interference with DNA topology (Topoisomerase inhibition).

03

Biological functions

DNA replicationDNA repairDNA recombinationGenome stabilityNucleotide metabolism
04

Disease associations

CancerGenetic disordersAging-related diseasesImmunodeficiency syndromesNeurodegenerative disease
05

Safety considerations

Myelosuppression (bone marrow suppression)Gastrointestinal toxicitySecondary malignanciesTeratogenicityGenotoxicity to healthy cells
06

Interacting drugs

Cisplatin

7 more in the full profile.

07

Biomarkers

BRCA1/2 mutation statusMicrosatellite instability (MSI)Tumor mutational burden (TMB)Homologous recombination deficiency (HRD)p53 mutation status

Beyond the preview

Go deeper on DNA metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call